Introduction
Maternal mortality remains a major global health concern, with postpartum hemorrhage (PPH) identified as one of the leading causes of death among mothers during or after childbirth. In Makueni County, like many other regions, maternal health outcomes have historically been affected by delayed response, inadequate treatment options, and the limitations of temperature-sensitive drugs such as oxytocin.
To address this challenge, the County Government of Makueni, through the Department of Health Services, partnered with Jhpiego, in collaboration with the International Federation of Gynecology and Obstetrics (FIGO) and the Kenya Obstetric and Gynecological Society, to introduce Heat Stable Carbetocin (HSC) in January 2024. HSC is a World Health Organization (WHO) recommended uterotonic drug for the prevention and treatment of postpartum hemorrhage. The drug does not require refrigeration and effectively controls bleeding after childbirth by stimulating uterine contractions.
The initiative aimed at improving maternal survival rates by enhancing PPH prevention and treatment in health facilities across the Makueni County. Through the systematic, County-wide adoption and integration of Heat Stable Carbetocin into routine emergency obstetric care, Makueni County.
Government has eradicated postpartum hemorrhage-related maternal deaths, strengthening maternal health systems and restoring hope for countless mothers.
One such mother is Faith Mumbe, a 28-year-old expectant mother from Mbiuni, Machakos County.
Click the link below to read more.